FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (II) and its crystalline form A, in which the X-ray powder diffraction pattern contains characteristic diffraction peaks at following angles 2θ: 3.30±0.20°, 6.33±0.20°, 6.55±0.20°, 10.62±0.20°, 12.57±0.20° and 13.11±0.20°, and crystalline form B, in which the X-ray powder diffraction pattern contains characteristic diffraction peaks at following angles 2θ: 12.12±0.20°, 16.48±0.20°, 16.95±0.20°, 17.94±0.20° and 21.87±0.20°. Invention also relates to a method of producing crystalline form B of a compound of formula (II), comprising (a) adding crystalline form A of the compound of formula (II) to a solvent to form a suspension; and (b) stirring suspension at 50 °C for 3 hours, filtering and drying, wherein the solvent is selected from a group consisting of isopropanol, tetrahydrofuran, acetonitrile, 2-butanone and ethyl acetate. According to the invention, the compound of formula (II) is used in preparing a drug for treating glaucoma or ocular hypertension.
EFFECT: invention discloses a salt form of an isoquinolinone type compound as an ROCK inhibitor and a method for preparing said compound.
17 cl, 7 dwg, 11 tbl, 9 ex
Title |
Year |
Author |
Number |
METHOD OF PRODUCING CRYSTALLINE FORM OF HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR |
2020 |
- Cai, Zhe
- Sun, Fei
- Ding, Charles Z.
|
RU2823673C1 |
CRYSTAL FORM AND SALT 3-(3,5-DICHLORO-4-HYDROXYBENZOIL)- 1,1-DIOXO-2,3-DIHYDRO-1,3-BENZOTHIAZOLE |
2018 |
- Uda, Junichiro
- Kobashi, Seiichi
- Hasegawa, Misa
|
RU2772043C2 |
SALTS AND CRYSTALLINE FORMS OF DIAZABENZOFLUORANTHENE COMPOUNDS |
2017 |
- Lu, Qingqing
- Shi, Shenyi
- Bai, Tiezhong
- Yuan, Shujie
- Li, Zhengwu
- Hu, Qiaofen
- Cao, Yijie
- Gao, Jing
- Ding, Hui
- Li, Jinhua
- Xu, Guanghai
- Wang, Zheng
- Jin, Xin
|
RU2762189C2 |
STABLE CRYSTALLINE FORM OF TIPIRACIL HYDROCHLORIDE AND METHOD FOR ITS CRYSTALLIZATION |
2014 |
- Kadzuno Khideki
- Mutsumi Tomonobu
|
RU2674441C1 |
INDAZOLE DERIVATIVE SALTS AND THEIR CRYSTALS |
2017 |
|
RU2747399C2 |
CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE |
2018 |
- Li, Syaolin
- Syao, Khualin
- Li, Pen
- Khe, Khajin
- Li, Vejdun
|
RU2800751C2 |
NEW CRYSTALS OF URACIL COMPOUND |
2016 |
|
RU2686722C1 |
AMINE SOLVATE OF SODIUM GLUCOSE OPENER OF SODIUM GLUCOSE OPENER AND METHOD FOR PRODUCTION THEREOF AND USE THEREOF |
2017 |
|
RU2710230C1 |
LSD1 INHIBITOR SALT AND ITS POLYMORPHIC FORM |
2019 |
- Chzhao, Lele
- Sun, Tszyantszyun
- Vu, Linyun
- Chen, Shukhuej
|
RU2794977C2 |
SALT OF MU-OPIOID RECEPTOR (MOR) AGONIST, CRYSTAL FORM I OF ITS FUMARATE SALT, AND THEIR PRODUCTION METHOD |
2018 |
|
RU2779119C2 |